Cyclo Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cyclo Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Cyclo Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.29M, a 73.9% decline year-over-year.
  • Cyclo Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$24.7M, a 27.3% decline year-over-year.
  • Cyclo Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$20.1M, a 28.3% decline from 2022.
  • Cyclo Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$15.6M, a 9.32% decline from 2021.
  • Cyclo Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$14.3M, a 59.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$24.7M -$8.29M -$3.52M -73.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$21.2M -$5.64M -$1M -21.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$20.2M -$5.12M -$114K -2.28% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$20.1M -$5.64M -$660K -13.2% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-12-18
Q3 2023 -$19.4M -$4.77M -$519K -12.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$18.9M -$4.63M -$1.18M -34.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$17.7M -$5.01M -$2.07M -70.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$15.6M -$4.98M -$2.19M -78.4% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-12-18
Q3 2022 -$13.4M -$4.25M -$389K -10.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$13M -$3.46M +$144K +4.01% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$13.2M -$2.93M +$1.1M +27.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$14.3M -$2.79M -$112K -4.17% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 -$14.2M -$3.86M -$2.42M -169% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$11.8M -$3.6M -$1.4M -63.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$10.4M -$4.04M -$1.4M -52.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$8.96M -$2.68M -$43.6K -1.65% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$8.92M -$1.44M +$193K +11.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$9.11M -$2.2M -$832K -60.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$8.28M -$2.64M -$734K -38.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$7.54M -$2.64M -$1.27M -92.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 -$6.27M -$1.63M -$839K -106% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$5.44M -$1.37M -$75.5K -5.84% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$5.36M -$1.91M -$1.09M -134% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$4.27M -$1.37M +$17.1K +1.24% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$4.28M -$790K -$153K -24% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$4.13M -$1.29M -$464K -55.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$3.67M -$814K +$176K +17.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$3.84M -$1.39M -$590K -74.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$3.25M -$637K +$974K +60.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$4.23M -$831K +$237K +22.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$4.46M -$990K -$257K -35.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$4.21M -$795K +$137K +14.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 -$4.34M -$1.61M -$871K -118% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$3.47M -$1.07M -$715K -203% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$2.76M -$733K -$351K -91.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$2.41M -$932K -$622K -201% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 -$1.79M -$740K -$543K -274% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$1.24M -$352K -$139K -65.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$1.1M -$383K -$541K -342% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$562K -$310K -$203K -191% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$359K -$198K -$94.7K -91.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$264K -$213K -$583K -158% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $318K $158K -$18.3K -10.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $337K -$106K -$276K -163% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-27
Q3 2013 $612K -$103K -$74.4K -260% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $687K $370K +$429K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $258K $177K +$100K +131% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $157K $169K +$234K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-04
Q3 2012 -$76K -$28.6K +$17.6K +38% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$93.6K -$59.3K -$100K -245% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $6.48K $76.3K +$80.7K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 -$74.3K -$64.4K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 -$46.2K -$32.1K -227% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $40.8K +$15.3K +60% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$4.43K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q3 2010 -$14.1K Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-02-23
Q2 2010 $25.5K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.